Autopsy report · NCT00221637

Efficacy of Valproate in Peripheral Neuropathic Pain

“slow recruitment and treatments beyond expiry date”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 years 6 months after it had already started.
• Ran for about 3 years 4 months before it stopped.
• 40 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2, Phase 3

Sponsor

University Hospital, Bordeaux

Sponsor type

University, hospital or other

Conditions

Neuralgia; Neuropathic Peripheral Pain

Interventions

Sodium Valproate

Participants

40

Sites

1

Countries

France

Trials that died the same way

• TPF Followed by Cetuximab and IMRT Plus Carbon Ion Boost for Locally Advanced Head and Neck Tumors
  “slow recruitment (only 8 patients recruited and treated until 12/2012)” (79% match in meaning)
• Propofol and Dexmedetomidin vs Midazolam Intraoperative Sedation and POCD
  “Too long recruitment period due to small number of patients” (74% match in meaning)
• Dose-Escalation Study Evaluating the Safety and Pharmacokinetics of Artesunate in Patients With Hepatocellular Carcinoma
  “slow recruitment of patients” (73% match in meaning)
• Metformin in Assisted Reproduction-MET-AR-study
  “Slow patient recruitment and expiry of study medication(aug2009)” (72% match in meaning)
• A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Lamivudine Resistant HBeAg-Negative Chronic Hepatitis B.
  “Low recruitment rate due to treatment regimen change” (72% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.